Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2B | P29275 | 3/20 | 0.39 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.39 |
| ▸ | CNR2 | P34972 | 9/20 | 0.37 |
| ▸ | HPGDS | O60760 | 1/20 | 0.37 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.36 |
| ▸ | BRD4 | O60885 | 1/20 | 0.36 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.35 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.35 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.34 |
| ▸ | RORC | P51449 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24813085 | 1.00 | ADORA2B (0.39) | ADORA2BADORA2ACNR2HPGDSCHRM5 | |
| SCHEMBL24811658 | 0.86 | CNR2 (0.35) | CNR2BRD4 | |
| SCHEMBL30865622 | 0.86 | CNR2 (0.35) | CNR2BRD4 | |
| SCHEMBL29239449 | 0.85 | HPGDS (0.41) | CNR2HPGDS | |
| SCHEMBL24811744 | 0.85 | HPGDS (0.41) | CNR2HPGDS | |
| SCHEMBL30865627 | 0.85 | CNR2 (0.48) | CNR2HPGDSBRD4TRPV1 | |
| SCHEMBL24811650 | 0.85 | CNR2 (0.48) | CNR2HPGDSBRD4TRPV1 | |
| SCHEMBL24810635 | 0.85 | IRAK4 (0.35) | CNR2TRPV1 | |
| SCHEMBL30164503 | 0.85 | IRAK4 (0.35) | CNR2TRPV1 | |
| SCHEMBL24810238 | 0.82 | HTR4 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117916232-A | Heterocyclic EGFR inhibitors for the treatment of cancer | 缆图药品公司 | 2024-04-19 | — | — | CN | disclosed |